6
Total investments
1
Early stage
0
Mid stage
1
Late stage
12y
Years active
Portfolio
2 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
2015
Cognition Therapeutics, Inc. is a clinical stage neuroscience company developing drugs that help restore normal cellular damage responses in neurodegenerative and neuro-ophthalmic disorders.
Board Member
2014
Headquartered in Austin, Texas, Lung Therapeutics, Inc. is a clinical stage biopharmaceutical company formed to leverage decades of leading research in orphan, pulmonary indications for which there are unmet medical needs. The company is developing a proprietary pipeline of therapeutics with the potential to greatly improve outcomes over currently available treatments. The company’s lead drug candidate, LTI-01, is in clinical development for Loculated Pleural Effusion (LPE) and has successfully completed a clinical trial in LPE patients. The company’s second drug candidate, LTI-03, is in clinical development for Idiopathic Pulmonary Fibrosis (IPF).
Experience · 8 entries
All (8)
Investments (6)
Founder (2)
Board (6)
2017
A
AbiliTech Medical
Board Member
2017
A
AbiliTech Medical
Board Member
2017
2015
A
Actuate Therapeutics
Board Member
2015
A
Actuate Therapeutics
Board Member
2015
Board Member
2015
Cognition Therapeutics, Inc. is a clinical stage neuroscience company developing drugs that help restore normal cellular damage responses in neurodegenerative and neuro-ophthalmic disorders.
Show all 8 entries ↓
Investment activity
2014–2017 · 6 investments
Recent (last 2 years)Earlier